In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes
- PMID: 10620608
- PMCID: PMC2195792
- DOI: 10.1084/jem.191.1.97
In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes
Abstract
Although DQA1*0301/DQB1*0302 is the human histocompatibility leukocyte antigen (HLA) class II gene most commonly associated with human type 1 diabetes, direct in vivo experimental evidence for its diabetogenic role is lacking. Therefore, we generated C57BL/6 transgenic mice that bear this molecule and do not express mouse major histocompatibility complex (MHC) class II molecules (DQ8(+)/mII(-)). They did not develop insulitis or spontaneous diabetes. However, when DQ8(+)/mII(-) mice were bred with C57BL/6 mice expressing costimulatory molecule B7-1 on beta cells (which normally do not develop diabetes), 81% of the DQ8(+)/mII(-)/B7-1(+) mice developed spontaneous diabetes. The diabetes was accompanied by severe insulitis composed of both T cells (CD4(+) and CD8(+)) and B cells. T cells from the diabetic mice secreted large amounts of interferon gamma, but not interleukin 4, in response to DQ8(+) islets and the putative islet autoantigens, insulin and glutamic acid decarboxylase (GAD). Diabetes could also be adoptively transferred to irradiated nondiabetic DQ8(+)/mII(-)/B7-1(+) mice. In striking contrast, none of the transgenic mice in which the diabetes protective allele (DQA1*0103/DQB1*0601, DQ6 for short) was substituted for mouse MHC class II molecules but remained for the expression of B7-1 on pancreatic beta cells (DQ6(+)/mII(-)/B7-1(+)) developed diabetes. Only 7% of DQ(-)/mII(-)/B7-1(+) mice developed diabetes at an older age, and none of the DQ(-)/mII(+)/B7-1(+) mice or DQ8(+)/mII(+)/B7-1(+) mice developed diabetes. In conclusion, substitution of HLA-DQA1*0301/DQB1*0302, but not HLA-DQA1*0103/DQB1*0601, for murine MHC class II provokes autoimmune diabetes in non-diabetes-prone rat insulin promoter (RIP).B7-1 C57BL/6 mice. Our data provide direct in vivo evidence for the diabetogenic effect of this human MHC class II molecule and a unique "humanized" animal model of spontaneous diabetes.
Figures






Similar articles
-
The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.J Clin Invest. 2001 Apr;107(7):871-80. doi: 10.1172/JCI11708. J Clin Invest. 2001. PMID: 11285306 Free PMC article.
-
Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans.Int Immunol. 2003 Sep;15(9):1035-44. doi: 10.1093/intimm/dxg103. Int Immunol. 2003. PMID: 12917255
-
Expression of the B7.1 costimulatory molecule on pancreatic beta cells abrogates the requirement for CD4 T cells in the development of type 1 diabetes.J Immunol. 2004 Jul 15;173(2):787-96. doi: 10.4049/jimmunol.173.2.787. J Immunol. 2004. PMID: 15240665
-
Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.J Autoimmun. 2011 Sep;37(2):122-8. doi: 10.1016/j.jaut.2011.05.001. Epub 2011 May 31. J Autoimmun. 2011. PMID: 21632210 Free PMC article. Review.
-
To B or not to B: role of B cells in pathogenesis of arthritis in HLA transgenic mice.J Autoimmun. 2011 Sep;37(2):95-103. doi: 10.1016/j.jaut.2011.05.002. Epub 2011 Jun 12. J Autoimmun. 2011. PMID: 21665435 Free PMC article. Review.
Cited by
-
Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic-polycytidylic acid) and an insulin self-peptide.Proc Natl Acad Sci U S A. 2002 Apr 16;99(8):5539-44. doi: 10.1073/pnas.082120099. Epub 2002 Apr 9. Proc Natl Acad Sci U S A. 2002. PMID: 11943868 Free PMC article.
-
A functional CD40 receptor is expressed in pancreatic beta cells.Diabetologia. 2005 Feb;48(2):268-76. doi: 10.1007/s00125-004-1645-7. Epub 2005 Feb 3. Diabetologia. 2005. PMID: 15690148
-
Understanding Autoimmune Diabetes through the Prism of the Tri-Molecular Complex.Front Endocrinol (Lausanne). 2017 Dec 14;8:351. doi: 10.3389/fendo.2017.00351. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 29312143 Free PMC article. Review.
-
Antigen-specific T cell responses in autoimmune diabetes.Front Immunol. 2024 Aug 15;15:1440045. doi: 10.3389/fimmu.2024.1440045. eCollection 2024. Front Immunol. 2024. PMID: 39211046 Free PMC article. Review.
-
Lessons for human diabetes from experimental mouse models.Curr Diab Rep. 2003 Apr;3(2):168-75. doi: 10.1007/s11892-003-0041-x. Curr Diab Rep. 2003. PMID: 12728643 Review.
References
-
- Todd J.A., Acha-Orbea H., Bell J.I., Chao N., Fronek Z., Jacob C.O., McDermott M., Sinha A.A., Timmerman L., Steinman L. A molecular basis for MHC class II–associated autoimmunity Science. 240 1988. 1003 1009[published erratum at 241:888] - PubMed
-
- Todd J.A. Genetic control of autoimmunity in type 1 diabetes. Immunol. Today. 1990;11:122–129 . - PubMed
-
- Todd J.A., Bell J.I., McDevitt H.O. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature. 1987;329:599–604 . - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous